BENCHMARKS
Surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry (SELDI-TOF-MS) allows for the rapid generation of peptide/protein (analyte) profiles from complex biofluids and tissues through the use of chemically modified ProteinChip ® arrays (Ciphergen Biosystems, Fremont, CA, USA). These arrays are designed to capture and retain subsets of proteins based on specific protein characteristics such as affinity, charge, hydrophobicity, and metal-binding capabilities. Spectral profiles obtained through the detection of enriched analyte can be compared to uncover patterns of differential abundance (1, 2) . The use of SELDI-TOF-MS to screen for patterns of differential protein expression has furthered biomarker discovery and aided in the identification of diagnostic patterns of disease and toxicity (3) (4) (5) (6) .
Although SELDI-TOF-MS is a robust platform for protein profiling, optimization of experimental procedures is required to ensure consistent data output. Confidence that differences in profile patterns specifically reflect changes in protein concentration is dependent in part on spectral reproducibility and quality, and these parameters are affected by multiple variables.
SELDI-TOF-MS, which incorporates matrix-assisted laser desorption/ ionization (MALDI), relies on the use of small ultraviolet (UV)-absorbing organic molecules (matrix) to transfer energy from a laser source to an associated analyte for desorption and ionization (7) . Therefore, consistency of matrix application and co-crystallization with surface-bound analytes could be critical to the output of consistent spectral data over time. We have been investigating the influence of matrix application timing on the resulting matrix-driven ionization and desorption of peptides/ proteins from the array surface. Based on previous observations and data published using the H4 ProteinChip array and sinapinic acid (SPA) (8), we suspected that variation in the matrix/analyte association through array-surface drying time contributes to variability in spectral output. To optimize procedures, a study was devised to determine the impact of drying time prior to matrix application on SELDI-TOF-MS reproducibility and quality across multiple ProteinChip array conditions. With informed consent, whole blood was collected from healthy human volunteers and processed for serum. Serum was diluted 1/100 in the specified binding buffer for the each ProteinChip array used (Table 1 ) and incubated on the array surface for 30 min in a humid chamber. Individual spots were washed with the same binding buffer followed by high-performance liquid chromatography (HPLC)-grade water. Freshly prepared saturated SPA (Ciphergen Biosystems) or 20% α-cyano-4-hydroxy cinnamic acid (CHCA; Ciphergen Biosystems) in 50% acetonitrile (ACN), 0.5% trifluoroacetic acid (TFA) was applied to the ProteinChip arrays after 0, 1, 2, 3, 5, 8, and 10 min of drying time past the final HPLCgrade water wash. This range of drying times was selected based on previous observations and preliminary data. Matrix-applied arrays were allowed to dry completely and stored in a dark, dessicated environment prior to mass spectrum collection. Duplicate spectra were generated using the ProteinChip Reader (Series PBSII; Ciphergen Biosystems) in three replicates. Low (between 0 and 20 kDa) and high (between 0 and 200 kDa) mass data were collected using automated data collection protocols in which laser intensity and detector sensitivity were set so that resulting peak heights fell below a relative intensity of 80 prior to baseline subtraction. Per spot, 130 spectral transient determinations were averaged, and the baseline was subtracted to obtain the final spectral output. Peak count, along with signal-to-noise ratios, were obtained using ProteinChip Software version 3.0 (Ciphergen Biosystems). Matrix peaks (0-1.5 kDa for CHCA and 0-8 kDa for SPA) were excluded, and data were normalized to the peak area. Significant (P < 0.01) differences in mean peak areas from the control (0 h) and in mean signal-to-noise ratios were determined by nonparametric one-way analysis of variance (ANOVA) followed by a Tukey multiple comparison test. Spectral reproducibility was defined as an overall pattern consistency in relation to peak area, whereas spectral quality refers to the measurement of peak count and the overall resolution of peaks compared to baseline (signalto-noise ratio).
Drying time-dependent differences were specific to the condition tested per combination of matrix, ProteinChip array, and buffer. Significant (P < 0.01) drying time-dependent changes in mean peak area were observed when CHCA, but not SPA, was applied to H4, WCX2, and LSAX30 ProteinChip arrays (Table 1) . Drying times greater than 3 min resulted in an overall loss of peak area when CHCA was applied to the sample-bound arrays, H4 and LSAX30. In contrast, an overall gain in peak area was observed when CHCA was applied for up to 10 min to the sample-bound WCX2 array. However, drying time prior to matrix application did not appear to affect peak area under the remainder of the conditions in which CHCA was applied ( Table 1) .
The LSAX30 ProteinChip array data illustrate a significant (P < 0.01) change in peak area (Figure 1 , A-C) and resolution ( Figure 1D ). Peak area decreased significantly by 8 min of drying time when compared to the con- Table 1 ). The resolution for the two peaks depicted was decreased due to the lowering of the signal-to-noise ratios ( Figure 1D ).
The H4 ProteinChip array had six peaks areas that changed significantly (P < 0.01) with extended drying times. Out of the six areas of significance, two peaks showed an increase in peak area and resolution, whereas the remaining four peaks decreased in both parameters (data not shown). Although spectral peak count did not change over time, significant (P < 0.01) changes in peak resolution were detected, showing trends similar to those seen with the LSAX30 array (data not shown).
In contrast to the LSAX30 and H4 data, an overall gain in peak area and resolution was observed when CHCA was applied to the WCX2 ProteinChip array. In this case, eight peaks of interest were found to significantly (P < 0.01) increase in peak area and resolution, while two peaks decreased in the same parameters (data not shown).
Drying time did not impact peak area and resolution under any condition in which SPA was applied to the array surface. This finding is interesting in that results published after this study was completed indicated that SPA applications to the H4 array following 60 min of drying time significantly (P < 0.01) increased reproducibility (8) . It is possible that a drying time of longer than 10 min may be required to observe significant differences with the protocol used in this study. It is also important to note that different binding conditions were used to retain analyte on the H4 array surface, which may confound this comparison.
Data reported in this study suggest that both spectrum reproducibility and quality for specific ProteinChip array conditions are impacted by extended drying times prior to matrix application. No clear evidence exists to explain why some conditions and not others are significantly (P < 0.01) affected with respect to peak area and resolution. It is possible that the analyte subsets retained under those conditions in which changes were seen are more susceptible to the matrix/analyte interaction than other subset populations. Those same protein species could also be interacting with the array surface differently over time, resulting in changes in folding during the drying process. Overall, it is imperative that consistency in matrix application timing be maintained to ensure that reproducible, quality spectral data are obtained routinely. With respect to these data, we recommend applying matrix to the ProteinChip arrays within 3 min after the final wash. BENCHMARKS resultant fragments is further destroyed at its unique restriction-purification site. The crude digestion products are ligated in situ to generate a single plasmid containing the two fragments that can be selected for directly. Two of the two-fragment plasmids are then ligated to make a plasmid with a four-fragment insert, and the process is continued recursively to lengthen the size of the insert in each cycle. Although the method has been developed to stitch together synthetic genes, a modified version could as well be used to ligate multiple DNA fragments from other sources (e.g., PCR). All enzymes were obtained from New England Biolabs (Beverly, MA, USA) and used as recommended. Molecular biological techniques were performed using standard protocols (2) . Synthetic DNA fragments were designed and prepared by a modification of reported methods (3) (4) (5) .
A linker duplex for uracil-DNA glycosylase-based ligation-independent cloning (UDG-LIC) (6,7) comprised of oligonucleotides UDG-L1 and UDG-L2, which contained a 5′ overhang [nucleotides (nt) [1] [2] [3] [4] A common operation in molecular biology involves the ligation or "stitching" of two or more adjacent sequences of DNA. In efforts directed towards the synthesis of a large number of very long polyketide synthase genes, we required a process to efficiently stitch multiple synthetic DNA fragments of 500-800 bp together to produce segments of up to 6 kbp. Multiple ligations of fragments are often performed one at a time into a vector, requiring n -1 (where n is the number of fragments) sequential cycles of cleavage, purification, and cloning for each of the inserts. Furthermore, because the fragment is produced or excised employing different restriction sites, the vector into which it is cloned must likewise contain the same restriction sites; this often requires specialized linkers that contain multiple cloning sites (MCS) co-linear with the fragments to be inserted. Efficiencies may be gained by parallel processing the ligation cycles, but significant time and effort is invested in isolation, purification, and cloning of inserts, which is scaled upwards by the number of large DNA sequences being prepared simultaneously.
In the present work, we describe a method, termed ligation by selection (LBS), for ligating multiple adjacent DNA fragments that does not require intermediate fragment isolation or specialized MCS linkers and is amenable to parallel processing and semiautomation. Fragments that ultimately are to lie adjacent to each other are each cloned into separate plasmid vectors that have a common antibiotic marker, a linking restriction site for joining the fragments, and a remote restriction site on the vector; in addition, each has a unique site to be used for restriction-purification (1) and a unique antibiotic marker ( Figure 1 ). Each vector is cleaved at the common restriction site and the remote site common to both. One of the four
